Date/Time:9–12 February 2026 Location:Dubai Exhibition Centre, UAE Official Congress Website:https://www.worldhealthexpo.com/events/healthcare/dubai/en/home.html YINGCHI Booth: # N29.F31 WHX Dubai 2026 marks a new chapter for one of the world’s most influential healthcare exhibitions. Formerly known as Arab Health, the event has evolved into World Health Expo (WHX), building on a 50-year legacy while reflecting the scale, diversity, and global reach... Read more
Major Depressive Disorder (MDD) is the leading cause of disability worldwide. Traditional medications and psychotherapy have limited efficacy in some patients. Although repetitive transcranial magnetic stimulation (rTMS) has been approved for MDD, the standard protocol has drawbacks including long treatment duration and slow onset of action. To improve treatment efficiency, reduce costs, and increase accessibility,... Read more
Date/Time :November 15-19, 2025 Location : San Diego, CA Official Congress Website：https://www.sfn.org/meetings/neuroscience-2025 YINGCHI Booth: #2910 Every year, the SfN annual meeting brings together thousands of scientists to discuss new findings, share ideas, and explore how neuroscience can continue to move forward. Its long-standing mission is to support scientific progress, encourage open exchange, and strengthen collaboration across different fields... Read more
Date/Time: November 17–20, 2025 Location: Düsseldorf, Germany Official Congress Website: https://www.medica-tradefair.com YINGCHI Booth: #Hall 9, Stand 54 Join YINGCHI at MEDICA 2025 MEDICA, the world’s leading medical trade fair, is back in 2025, bringing together innovators, experts, and companies from around the globe. As in previous years, YINGCHI is ready to meet you again and showcase... Read more
Date/Time: October 5–8, 2025 Location: Prague Congress Centre, Prague, Czech Republic Official Congress Website: https：//wcp-comgress.com/ YINGCHI Booth: #13 Join YINGCHI at the World Congress of Psychiatry This October, YINGCHI will participate in the 25th World Congress of Psychiatry (WCP 2025), organized by the World Psychiatric Association (WPA) in Prague, Czech Republic. With the theme “The Role... Read more
The first onset of major depressive disorder (MDD) during adolescence is often associated with a lifelong risk of recurrence and functional impairment, making early and effective intervention crucial for adolescent patients with depression. However, pharmacological treatments are slow-acting and may have side effects, while psychotherapy is time-consuming and unable to rapidly alleviate symptoms. Therefore, developing... Read more
